Yokohama City University Medical Center is a general hospital located in Minami-ku, Yokohama, Japan. Founded in 1871, it is the second oldest western-style hospital in Japan.

There are 726 beds in Yokohama City University Medical Center.

During the past decade, Yokohama City University Medical Center conducted 45 clinical trials. In the 10-year time frame, 45 clinical trials started and 11 clinical trials were completed, i.e. on average, 24.4% percent of trials that started reached the finish line to date. In the past 5 years, 28 clinical trials started and 10 clinical trials were completed. i.e. 35.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Yokohama City University Medical Center" #1 sponsor was "Janssen Research & Development, LLC" with 11 trials, followed by "Yokohama City University Medical Center" with 9 trials sponsored, "Eli Lilly and Company" with 8 trials sponsored, "Pfizer" with 4 trials sponsored and "Janssen Pharmaceutical K.K." with 4 trials sponsored. Other sponsors include 24 different institutions and companies that sponsored additional 25 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Yokohama City University Medical Center" #1 collaborator was "Astellas Pharma Inc" with 2 trials as a collaborator, "Japan Agency for Medical Research and Development" with 2 trials as a collaborator, "Alpha-A, Inc." with 1 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator and "Boehringer Ingelheim" with 1 trials as a collaborator. Other collaborators include 7 different institutions and companies that were collaborators in the rest 17 trials.

According to Clinical.Site data, the most researched conditions in "Yokohama City University Medical Center" are "Prostatic Neoplasms" (4 trials), "Ulcerative Colitis" (4 trials), "Atrial Fibrillation" (3 trials), "Coronary Artery Disease" (3 trials) and "Crohn's Disease" (3 trials). Many other conditions were trialed in "Yokohama City University Medical Center" in a lesser frequency.

Most popular intervention types in "Yokohama City University Medical Center" are "Drug" (52 trials), "Procedure" (6 trials), "Biological" (4 trials), "Other" (3 trials) and "Radiation" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (13 trials), "Abemaciclib" (3 trials), "Guselkumab" (3 trials), "Guselkumab Dose 1" (3 trials) and "Guselkumab Dose 2" (3 trials). Other intervention names were less common.

The vast majority of trials in "Yokohama City University Medical Center" are 53 trials for "All" genders, 9 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Yokohama City University Medical Center". undefined are not yet recruiting, 25 are recruiting, 10 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 18 completed trials in Yokohama City University Medical Center, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Yokohama City University Medical Center, 1 "Phase 1" clinical trials were conducted, 18 "Phase 2" clinical trials and 31 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 3 trials that are defined as “Not Applicable".